Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.68%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.01M | -19.68M | 3.76M | -45.50M | -23.52M |
| Total Depreciation and Amortization | 765.90K | 745.50K | 754.10K | 749.70K | 741.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.63M | -1.14M | -20.08M | 23.90M | 1.87M |
| Change in Net Operating Assets | -171.70K | -1.51M | -3.81M | -730.40K | 94.40K |
| Cash from Operations | -18.05M | -21.59M | -19.37M | -21.57M | -20.81M |
| Capital Expenditure | -- | -- | -127.40K | -68.00K | -30.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.15M | 2.64M | 69.30K | 8.94M | 5.31M |
| Cash from Investing | 6.15M | 2.64M | -58.20K | 8.87M | 5.28M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.25M | 1.08M | 27.13M | 7.94M | 0.00 |
| Repurchase of Common Stock | -56.00K | -130.20K | 0.00 | -1.80K | -34.80K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.96M | -- | 0.00 | 16.99M | -- |
| Cash from Financing | 17.16M | 953.80K | 27.13M | 24.92M | -34.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.25M | -18.00M | 7.71M | 12.22M | -15.56M |